Pharma and BioTech Daily
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what's important in pharma and biotech. Each weekday it condenses key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. The show is produced by OWITH.ai, a boutique AI & data studio.
Episodes
GSK Invests $800M in Biologics Facility | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.
Today, we're diving into some of the most compelling stories shaping the industry. Let's begin with GSK's bold move to expand its biologics capabilities. The company has announced an $800 million investment in a new biologics production facility and i
Asahi Kasei's $920M AiCuris Buy Leads to FDA OK | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of compelling stories that highlight the dynamic nature of the industry, marked by strategic acquisitions, groundbreaking research, and significant regulatory milestones.
Starting with Asahi Kasei's acquisition of Bayer spinout AiC
GSK AI Partnership & Roche's FDA Win: $117M IPO Buzz | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of significant advancements and strategic shifts shaping the industry landscape.
We begin with the integration of artificial intelligence into drug discovery. GSK's recent collaboration with Chai Discovery exemplifies the
Novartis' Rhapsido FDA Expansion Boosts Revenue Potential | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most significant advancements and challenges shaping these dynamic sectors.
In a notable regulatory update, the U.S. Food and Drug Administration has expanded the label for Novartis' Rhapsido to include symptomatic dermographism
Cerevance's Solengepras Hits Phase 3 Success for Parkinson's | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of impactful advancements and strategic shifts shaping the industry landscape.
Cerevance has made headlines with its drug Solengepras achieving a major milestone in a Phase 3 trial for Parkinson's disease. The drug signifi
Shionogi Acquires Intrabio for $2B: Rare Disease Focus | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.
The pharmaceutical industry is no stranger to dynamic growth, as evidenced by Shionogi's recent acquisition of Intrabio for a staggering $2 billion. This move is more than just a financial transaction; it represents a strategic pivot towards addressing rare dis
Bayer's $2.2B Ohio Site Boosts U.S. Pharma | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of groundbreaking advancements and strategic shifts that are defining the industry's path forward.
Bayer has made headlines with its strategic $2.2 billion investment in a new Ohio manufacturing site. This move highlights
Novartis's $7.8B mRNA Deal with Abogen | Pharma and Biotech Daily
Good morning from Pharma Daily, the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the rapidly evolving landscape of drug development, where groundbreaking scientific advances and strategic corporate maneuvers are reshaping patient care and industry standards.
The integration of artificial intelligence in drug discovery is gai
Sanofi's $1B Deal with Regeneron: Immunology Breakthroughs | Pharma and Biotech Daily
Good morning from Pharma Daily, the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape is constantly evolving, with innovative partnerships, groundbreaking clinical trial results, and regulatory shifts shaping the future of healthcare. Today, we delve into these key areas, highlighting significant industry movements and their potential im
Eli Lilly's Retatrutide: 25% Weight Loss in Phase 3 Trial! | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the latest breakthroughs and trends shaping the landscape of medicine and treatment.
In the realm of weight management and metabolic disorders, significant advancements are underway. Roche and Zealand Pharma have moved Petrelintide, an amylin an
AstraZeneca's $2B Oncology Investment | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.
Today, we delve into a series of transformative developments across the pharmaceutical and biotech sectors, highlighting strategic investments, innovative therapies, and regulatory milestones.
AstraZeneca's recent $2 billion investment in Summit Therapeutics i
AbbVie Juvmo FDA Approved: Parkinson's Breakthrough | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Recent updates in these sectors have highlighted significant scientific advancements, regulatory milestones, and promising clinical trial results that could impact patient care and drug development.
One of the standout developments is the FDA's approval of AbbV
Merck's FDA Win: Welireg & Lenvima Breakthrough | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape of these industries is currently experiencing a wave of transformative changes, from strategic corporate relocations and groundbreaking partnerships to pivotal regulatory approvals and promising clinical trial outcomes.
Let's begin with a signific
Eli Lilly's $2B Onswik FDA Approval Revolutionizes Diabetes | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of recent breakthroughs and strategic moves that are shaping the future of drug development and patient care.
Eli Lilly has achieved a significant milestone with the FDA's approval of Onswik, a once-weekly insulin therapy
AstraZeneca's Trixeo EU Approval & Boehringer's $250M Deal | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the dynamic landscape of scientific advances and strategic collaborations shaping patient care and drug development globally.
AstraZeneca recently achieved a significant milestone with the European Union's approval of Trixeo, a combination
Boehringer Ingelheim's $1B AI Deal & FDA Trials Update | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The industry is pulsating with advancements, strategic collaborations, regulatory approvals, and promising clinical trial results that are reshaping the landscape of healthcare and drug development.
A notable collaboration making waves is between Boehringer Ingelhei
Telix Buys ITM for $2.35B | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a period of profound transformation within the industry, marked by scientific advancements, strategic acquisitions, and a shifting regulatory landscape that promises to redefine the future of healthcare.
Telix Pharmaceuticals has made headlines
Ultragenyx’s $4M Fayuvi FDA Approval Breakthrough | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of groundbreaking advancements and strategic shifts shaping the future of this dynamic industry.
The FDA has recently approved Ultragenyx's gene therapy, Fayuvi, for a rare neurodegenerative disorder, marking a significant mileston
Bayer's Kerendia Secures 3rd FDA Approval | Pharma and Biotech Daily
Good morning from Pharma Daily, the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of pivotal advancements and strategic maneuvers shaping the landscape of drug development and patient care.
Bayer's Kerendia, known generically as finerenone, has achieved its third FDA approval, this time targeting chroni
Novartis Acquires Sironax Platform for $125M | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of dynamic and significant advancements across the industry, from strategic acquisitions to regulatory shifts and scientific innovations.
In a bold move, Novartis has acquired Sironax's blood-brain barrier delivery platfor
GSK Acquires Chimagen's Tech for $750M | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant strides and strategic maneuvers reshaping the landscape of healthcare and drug development.
Kicking things off, GlaxoSmithKline (GSK) has made headlines with its acquisition of Chimagen Biosciences' trispecific T cel
Scholar Rock's $20B Pharma Shakeup & More | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today’s episode delves into some of the latest breakthroughs, regulatory updates, and strategic maneuvers reshaping the landscape of drug development and patient care.
Starting with remarkable advancements in drug approvals, Scholar Rock's Isembldy (apitegromab
Moderna's $1B mRNA Cancer Vaccine Boosts Personalized Meds | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.
First, let's delve into the innovative work being done by Grove Biopharma. Founded in 2020 in Chicago, this company is at the forefront of developing polymer-peptide hybrids to target intracellular protein-protein interactions, areas traditionally deemed undrug
FDA Expands Bayer's Hyrnuo Approval | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the significant advancements and challenges that are shaping the future of drug development, regulatory landscapes, and industry innovations.
Starting with a major milestone in personalized cancer therapy, the FDA has expanded Bayer's appro
Sandoz Invests $2.5B in Biosimilars Network | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.
Sandoz's recent move to invest $2.5 billion in creating a vertically integrated biosimilar manufacturing network is making waves across the industry. This significant investment underscores the growing importance of biosimilars as cost-effective alternatives to
AstraZeneca's $116M FDA Win: New Breast Cancer Drug | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we unveil a series of transformative strides in drug approvals, clinical trials, and regulatory landscapes that are reshaping the future of patient care.
AstraZeneca's camizestrant, now branded as Etcamah, has received FDA approval for treating ESR1-muta
FDA Approves Alzheimer's Drug: Major $ Breakthrough | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In today's episode, we're diving into a series of breakthroughs and significant updates that are shaping the landscape of medicine and treatment.
Let's start with a remarkable development in the realm of personalized medicine. Researchers have announc
Ionis' Zanvastro FDA Approved: $771M Partnership Impact | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of pivotal advances and industry dynamics that are shaping the future of healthcare.
The U.S. Food and Drug Administration has recently granted approval to Ionis Pharmaceuticals' Zanvastro, a breakthrough in treating Alexander dise
Summit & Akeso's Ivonescimab Beats Keytruda in NSCLC Phase 3 | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of fascinating updates that are shaping the future of medicine and patient care.
First on our agenda is uniQure's ambitious step toward accelerated U.S. marketing approval for AMT-130, a gene therapy targeting Huntington&a
AstraZeneca & Roche Secure EU Breast Cancer Approval | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into groundbreaking scientific advancements, crucial regulatory updates, and strategic industry movements that are shaping the future of patient care and drug development.
AstraZeneca, in collaboration with Daiichi Sankyo, has achieved a significant
Novartis' Rhapsido Hits Phase 3 Goals for MS | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into the dynamic landscape of the industry, highlighting significant scientific breakthroughs, strategic partnerships, and regulatory updates that are reshaping healthcare as we know it.
Novartis recently announced a major milestone with its BTK inhib
Eli Lilly Acquires Merida for $2.9B | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.
The current landscape in the pharmaceutical and biotech industries is a tapestry of dynamic mergers, clinical trial advancements, regulatory approvals, and strategic partnerships. A major highlight is Eli Lilly's acquisition of Merida Biosciences for up to $2.9
Eli Lilly's $173M FDA Win: Mounjaro Approved! | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant advancements and regulatory milestones that underscore the industry's commitment to addressing complex health challenges with innovative therapeutics and strategic investments.
Eli Lilly has achieved a major breakthr
Revolution Medicines' $2.25B FDA Approval Milestone | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we explore groundbreaking advancements, regulatory updates, and strategic partnerships shaping the future of patient care and drug development.
Revolution Medicines has achieved a significant milestone with the FDA approval of its RAS inhibitor, daraxonrasib,
Revolution Medicines FDA Win: RAS Inhibitor Approved | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Let's dive right into today's top stories, where pioneering advancements and strategic shifts are reshaping how we understand and treat complex diseases.
In recent developments, Akeso's PD-1xVEGF bispecific antibody ivonescimab is making waves beyond
FDA Extends Capricor Review: $2.25B McKesson Deal | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the latest happenings in these dynamic sectors, where scientific advancements, regulatory decisions, and strategic business initiatives are continuously reshaping the landscape of healthcare.
Starting with a significant regulatory update, the FD
Roche & Hanmi's $2.5B Obesity Drug Deal | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In the rapidly evolving landscape of pharmaceutical and biotechnology sectors, several significant developments have marked recent progress in drug development, clinical trials, regulatory approvals, and industry partnerships.
A landmark partnership between Roche an
Roche's $750M Genentech Expansion Boosts Biologics | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the latest strategic moves, regulatory updates, and scientific breakthroughs shaping these dynamic industries.
Roche is making headlines with its substantial $750 million investment to expand its Genentech facility in Oregon. This expansion is s
Ultragenyx's $97M Gene Therapy Breakthrough! | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the latest advancements and achievements across this dynamic industry, where innovation is reaching new heights and regulatory landscapes are continuously evolving.
In a groundbreaking moment for gene therapy, Ultragenyx has sec
Merck's $1B Melanoma Vaccine Breakthrough | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into recent strides made in scientific research, regulatory landscapes, and market dynamics that are shaping the future of healthcare.
Starting with a significant breakthrough in cancer treatment, Merck & Co. and Moderna have reported pr
Biokin's $275M ADC Success in Phase 3 Trial | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of updates that underscore the dynamism and complexity of these industries, marked by breakthroughs, strategic shifts, and regulatory hurdles.
A notable scientific advancement comes from Biokin Pharma, where their bispecific antibody-dr
AstraZeneca Tagrisso Breakthrough: Phase 3 Success in NSCLC | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're delving into a series of groundbreaking updates that could significantly impact drug development and patient care.
Vera Therapeutics recently announced promising Phase 3 clinical trial results for its monoclonal antibody, Trutakna, in treating immu
FDA Fast-Tracks NASH Drug | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the latest breakthroughs, regulatory updates, and clinical trial results shaping our industry.
Recently, a significant milestone has been achieved in gene therapy. A new study showcases a groundbreaking approach to treating rare genetic
AstraZeneca's Baxfendy Setback: Pricing Woes | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Recent weeks have showcased a dynamic landscape in these sectors, marked by scientific breakthroughs, regulatory updates, and strategic business decisions that are collectively reshaping the future of drug development and patient care.
AstraZeneca recently faced cha
Akeso's Ivonescimab Wins NSCLC Approval in China | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.
Today, we're diving into a series of compelling stories that underscore the dynamic shifts and groundbreaking progress within the industry.
Recently, Akeso's ivonescimab received a landmark approval for first-line treatment of non-small cell lung cancer (
Bristol Myers Squibb's $2.3B Texas Investment Boosts Jobs | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the dynamic landscape of drug manufacturing, regulatory affairs, and scientific breakthroughs that are shaping the future of patient care and therapeutic innovation.
Bristol Myers Squibb has made headlines with its substantial $2.3 billion inves
Novo Nordisk & AWS Partner for AI Drug Discovery Breakthrough | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a landscape marked by remarkable scientific breakthroughs, strategic alliances, and regulatory milestones that are shaping the future of healthcare.
Novo Nordisk is making waves with its new partnership with Amazon Web Services, utilizi
Replimune's FDA Win: Tudriqev Approved After 2 Rejections | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today's episode delves into the latest innovations and strategic shifts propelling the industry forward.
A notable dialogue emerging in psychiatric drug development comes from TLDR Biotech's engagement with Shlomi Raz and Ken Belotsky, co-founders of Palom
Moderna mRNA Flu Vaccine Approved by FDA | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're delving into a series of pivotal advancements that underscore the dynamic nature of our industry.
Starting with Moderna, which has recently secured FDA approval for its mRNA-based influenza vaccine, MFLUSIVA. This marks a monumental leap in leverag
Eli Lilly's $23B Q2 Revenue Breaks Records | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the intricate web of scientific advancements, regulatory updates, and strategic maneuvers shaping the industry.
Let's begin with Eli Lilly's impressive financial performance, clocking a record-breaking $23 billion in revenue for Q2 202
Otsuka's Voyxact Shines in Phase 3 Trial | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the latest scientific advancements, regulatory milestones, and strategic business maneuvers shaping the industry.
One of the standout developments comes from Otsuka with their drug Voyxact, which has shown promising results in s
Supernus & Indivior $2.2B Merger Creates CNS Giant | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into recent transformative events that are shaping this dynamic industry, from strategic mergers to groundbreaking drug approvals.
Starting with the merger between Supernus Pharmaceuticals and Indivior Pharmaceuticals, this all-stock deal valued at $
Replimune's Breakthrough in Cancer Therapy | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Recent weeks have been a whirlwind of activity in the pharmaceutical and biotech sectors, showcasing significant strides in scientific breakthroughs, regulatory advancements, and strategic industry maneuvers.
Replimune's Vusolimogene Oderparepvec has emerged as
Johnson & Johnson's $785M CAR-T Deal & More | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of events that underscore the dynamic nature of these industries, characterized by scientific advancements, strategic partnerships, and regulatory milestones.
Johnson & Johnson has made headlines with its substantial $785 million up
Biogen Acquires Apellis for Growth | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.
Biogen has made a significant acquisition by purchasing Apellis Pharmaceuticals, a move expected to boost its 2026 revenue guidance with promising growth prospects. This strategic acquisition, along with strong sales from new drugs, enhances Biogen's position i
GlaxoSmithKline's $2.5B Restructuring Near AstraZeneca | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into the latest news shaping these dynamic sectors, exploring strategic corporate maneuvers, groundbreaking scientific advances, and pivotal regulatory changes.
GlaxoSmithKline (GSK) is embarking on a comprehensive restructuring initiative aimed at ac
AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a wealth of significant advancements and strategic moves shaping the industry landscape.
AstraZeneca is making waves with its steadfast commitment to reaching an $80 billion revenue target by 2030. This ambitious goal is underpinned by
Scribe Therapeutics Raises $129M in IPO | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into the latest groundbreaking advancements, strategic corporate maneuvers, and pivotal regulatory updates shaping this dynamic industry landscape.
Starting with some exciting news, Scribe Therapeutics has successfully closed its initial pub
Eli Lilly's Retatrutide: 22.6% Weight Loss in Phase 3! | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the most exciting scientific breakthroughs and regulatory developments that are shaping the future of healthcare.
Eli Lilly's retatrutide, a promising small molecule GLP-1 receptor agonist, has achieved significant results
Repligen Buys BioLife for $1.5B | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're delving into a series of significant breakthroughs and strategic moves reshaping the industry landscape.
Repligen Corporation's recent decision to acquire BioLife Solutions for $1.5 billion marks a pivotal moment in the cell therapy sector. Bi
Bristol Myers & NVIDIA's $1.5B AI Deal: Game Changer? | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Recent advancements in these sectors highlight a fascinating intersection of technology and medicine, underscoring a push towards innovation that promises to reshape healthcare delivery.
Bristol Myers Squibb has expanded its collaboration with NVIDIA, aiming to crea
Samsung Biologics' $1.8B Peptide Expansion | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're navigating through a myriad of transformative advancements reshaping the industry. From artificial intelligence-driven research breakthroughs to strategic acquisitions in emerging therapeutic areas, these developments are setting new benchmarks in d
Jasper Merges with Kira for $292M | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of industry-shaping events, reflecting the ever-evolving landscape of drug development, regulatory challenges, and strategic maneuvers.
In a significant move within the sector, Jasper Therapeutics has merged with Kira Pharmaceuticals, a
Recommended
The Swerve Podcast: Obscure Topics | Conspiracy Theories
The Bread and Banter Podcast
The Church of What's Happening Now: The New Testament
Busted Open
Deadline: White House
Crickets Corner
History of the Earthquake and Fire in San Francisco
Fox news
K-Drama Obsessed Mamas | Beyond “Just One More Episode!”
True Crime Classics
The Healer Revolution
Becoming: HER with Nikki Spoelstra
